Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Geratherm Medical AG's FCF Margin % or its related term are showing as below:
XTER:GME'
s FCF Margin % Range Over the Past 10 Years
Min: -15.06 Med: -0.3 Max: 8.51
Current: 4.44
During the past 13 years, the highest FCF Margin % of Geratherm Medical AG was 8.51%. The lowest was -15.06%. And the median was -0.30%.
XTER:GME's FCF Margin % is ranked better than 61.1% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs XTER:GME: 4.44
The historical data trend for Geratherm Medical AG's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:GME vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Geratherm Medical AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Geratherm Medical AG FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Geratherm Medical AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Geratherm Medical AG (XTER:GME) has a FCF Margin % of 1.71% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Geratherm Medical AG and its competitors. According to the industry distribution chart, Geratherm Medical AG ranks #317 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 38.9%.
Is Geratherm Medical AG's FCF Margin % too high?
Geratherm Medical AG's current FCF Margin % is 1.71%. Based on the distribution chart, Geratherm Medical AG ranks #317 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Geratherm Medical AG has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Geratherm Medical AG's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Geratherm Medical AG ranks #317 out of 815 companies for FCF Margin %. This puts Geratherm Medical AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Geratherm Medical AG and its competitors. Geratherm Medical AG's current FCF Margin % is 1.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Geratherm Medical AG stock overvalued right now?
Based on GuruFocus' analysis, Geratherm Medical AG (XTER:GME) is currently considered Modestly Undervalued. The stock's GF Value™ is €3.16, compared to a current price of €2.63 — trading 16.8% below its estimated fair value. The current FCF Margin % is 1.71%. Geratherm Medical AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Geratherm Medical AG (XTER:GME), the current FCF Margin % is 1.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Geratherm Medical AG (XTER:GME) Overvalued in 2026?
Based on GuruFocus' analysis, Geratherm Medical AG stock appears to be undervalued.
The current stock price of €2.63 is trading 16.8% below its estimated GF Value™ of €3.16.
GuruFocus considers Geratherm Medical AG to be Modestly Undervalued.
Key valuation signals for XTER:GME:
FCF Margin %: 1.71%
GF Value™: €3.16 vs. price of €2.63 (16.8% below fair value)
No single metric tells the full story. See the XTER:GME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
72GF Score
Get the complete analysis for XTER:GME
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:GME has been successfully added to your 
